secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001193125-23-265621
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest regains Nasdaq minimum bid price compliance
---------------------------------------------------

- Received formal Nasdaq notification on Oct 26, 2023, confirming compliance with Listing Rule 5450(a)(1).
- Rule requires closing bid price of at least $1.00 per share for continued listing.
- Regaining compliance removes potential delisting risk for TPST common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312523265621/0001193125-23-265621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312523265621/d559172d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-265621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer